Amarantus Bioscience Holdings Inc (AMBS)

[Mgoblue10]

As the person who brought attention to the term 'qualitative', let me provide additional insight to my interpretation of the word. First, I am an engineer and therefore come with a scientific and practical background. I personally compose, review and approve technical communication/correspondence on a daily basis and am very much sensitive to the use of the terms qualitative vs. quantitative. Regardless of industry, anything qualitative simple refers to the absence of numerical data. As such, I assumed that the CC would not contain numerical estimates of forward revenues, which is something I was hoping to see. I am quite certain the qualitative revenue guidance will be both impressive and eye-opening. For me personally, I was looking forward to hearing actual revenue dollar forecasts, which, I now believe will no longer be forthcoming in the near future. This assumption led me to continue to assume that expectations have not been met internally and the timeline for progress continues, which, btw, is not uncommon for any of us in our professional lives, delayed. I apologize for spurring controversy or calling into question GC's credibility. Simply put, in my opinion, they are further out than I was hoping/expecting.